FDA issues continuous manufacturing advice to build an agile pharma industry
Pharmaceutical Technology
MARCH 2, 2023
On 1 March, the FDA issued the International Council for Harmonisation (ICH) final guidance on the use of continuous manufacturing in drug production. This publication marks the FDA’s proactive steps to ease the pharmaceutical’s industry transition to these advanced processes, states the announcement.
Let's personalize your content